1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Belgium >
  5. Invitae Acquires Diploid

M&A Deal Summary

Invitae Acquires Diploid

On March 10, 2020, Invitae acquired medical products company Diploid for 95M USD

Acquisition Highlights
  • This is Invitae’s 1st transaction in the Medical Products sector.
  • This is Invitae’s 3rd largest (disclosed) transaction.
  • This is Invitae’s 1st transaction in Belgium.

M&A Deal Summary
Date 2020-03-10
Target Diploid
Sector Medical Products
Buyer(s) Invitae
Deal Type Add-on Acquisition
Deal Value 95M USD

Target

Diploid

Leuven, Belgium
Diploid provides clinical labs, hospitals and nation-wide sequencing programs with the tools to diagnose every rare disease patient. Its Moon platform is the first software worldwide to use artificial intelligence for rare disease diagnostics. Diploid was established in 2014 and is based in Leuven, Belgium.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Invitae

San Francisco, California, United States
Category Company
Founded 2010
Sector Life Science
Employees1,700
Revenue 516M USD (2022)
DESCRIPTION

Invitae is a genetic information company diagnostics for hereditary disorders. Invitae was founded in 2010 and is based in San Francisco, California.

DEAL STATS #
Overall 10 of 13
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 10 of 13
Country: Belgium M&A 1 of 1
Year: 2020 M&A 3 of 4
Size (of disclosed) 3 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-10 YouScript

Seattle, Washington, United States

YouScript is a clinical decision support and analytics platform. Its software pairs a patient's pharmacogenetic profile with published drug and gene interaction information to assess the risk of adverse drug events and possible side effects. YouScript was established in 2016 and is based in Seattle, Washington.

Buy $79M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-22 ArcherDX

Boulder, Colorado, United States

ArcherDX is a genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable, and easy to use in local settings. ArcherDX was formed in 2013 and is headquartered in Boulder, Colorado.

Buy -
Mergr

Solution for

Product

Company

Legal